ProNoxis AB
Developing small molecule drugs targeting NOX2 activation for inflammation treatment.
Oversikt
- 1
- Ansatte
- 212t SEK
- Omsetning
- 2008
- Grunnlagt
Nøkkelbeslutningstakere
Peter Olofsson
Chairman & CEO
Beskrivelse
ProNoxis is a specialized biotechnology company focused on the preclinical exploration of novel small-molecule therapeutics. Its core mission is developing oral drugs to treat chronic inflammatory, autoimmune, and infectious diseases. The company targets a unique mechanism by developing agonists tha...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556773234101
Beslutningstakere
1 kontakter i FunnelfeedrPeter Olofsson
Chairman & CEO
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Redoxis AB
19 ansatteSwedish CRO specializing in preclinical autoimmune and inflammatory disease models.
Inicure AB
0 ansatteDeveloping novel small molecules to combat resistant bacterial infections effectively.
Active Biotech AB (publ)
1–4 ansatteDeveloping novel treatments for cancer and inflammatory eye diseases.
VACARA AB
2 ansatteSwedish biotech developing RA diagnostics, vaccines, and therapeutics.
Novakand Pharma AB
5–9 ansatteDeveloping novel small-molecule drugs for inflammation and cancer.
Utforsk mer
Spørsmål om ProNoxis AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo